VIVO
Index
Log in
Search form
Menu
Home
People
Organizations
Research
Events
A Phase 3 Trial to Evaluate the Safety and Efficacy of Triple Therapy With Saxagliptin and to Dapagliflozin ......
Grant
Overview
Affiliation
Identity
View All
Overview
date/time interval
July 12, 2012 - July 12, 2018
awarded by
Bristol Myers Squibb Company Pharmacy Research Institute
administered by
Medicine - Jacksonville
total award amount
86334.87
direct costs
69067.90
local award ID
00103886
Affiliation
contributor
Chehade, Joe
Principal Investigator
2012 - 2015
Identity
PeopleSoft Contract Number
00103886